Your Best Stock
Stocks › Biotechnology › ARGX

argenx SE ARGX

US equityMarket cap rank #269Biotechnology
$955.32
+$9.50 (+1.00%)
Market open · Sep 24, 2:00 pm ET
After hours $945.82 0.00%
Open$945.81
Prev close$945.82
Day range$944.21 – $965.27
Volume219.2K
Market cap$59.77B
P/E (TTM)36.4
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$1.52B+59.6% YoY
Operating profit$494.00M+145.8% YoY
Net profit$472.00M+91.9% YoY
Diluted EPS$7.48+100.0% YoY
Free cash flow$267,297.05+113.2% YoY
Operating cash flow$309,579.13

Revenue, last 8 quarters

$573.0MSep '24$741.3MDec '24$790.0MMar '25$949.0MJun '25$1.1BSep '25$1.3BDec '25$1.3BMar '26$1.5BJun '26

Net profit, last 8 quarters

$91.4MSep '24$774.2MDec '24$169.0MMar '25$246.0MJun '25$344.3MSep '25$533.0MDec '25$366.0MMar '26$472.0MJun '26

Diluted EPS by quarter

1.39Sep '2411.87Dec '242.58Mar '253.74Jun '255.18Sep '258.06Dec '255.52Mar '267.48Jun '26

Free cash flow by quarter

$-3.5MMar '13$-2.0MJun '13$-3.2MMar '14$267.3KJun '14

Annual revenue

$41.2MFY20$497.3MFY21$410.7MFY22$1.2BFY23$2.2BFY24$4.2BFY25

Profitability & balance sheet

Gross margin90.0%
Operating margin30.7%
Net margin32.8%
Return on equity23.6%
Return on assets19.9%
Return on invested capital21.1%
Current ratio5.12
Liabilities / assets16.1%
Cash & investments$5.18B
Total debt$36.00M
Net cash (debt)$5.15B
Free cash flow / sales17.3%

Where the revenue comes from

Quarter 2025/FY

By region

  • United States$3.53B 85.1%
  • Rest of the World$342.62M 8.3%
  • Japan$206.84M 5.0%
  • China$67.92M 1.6%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $1.52B $1.30B – – $1.13B
Total Operating Revenue $1.52B $1.30B $4.15B $1.29B $1.13B
Cost of Revenue $145.00M $121.00M $450.67M $149.69M $109.43M
Gross Profit $1.37B $1.18B $3.70B $1.14B $1.02B
Operating Expense $876.00M $783.00M $2.65B $778.63M $667.57M
Selling and Admin Expenses $411.00M $355.00M $1.36B $422.54M $336.29M
Research & Development $486.00M $443.00M $1.36B $371.71M $355.65M
Other Operating Expenses -$26.00M -$15.00M -$82.99M -$22.70M -$24.38M
Operating Profit $494.00M $394.00M $1.05B $359.56M $349.97M
Net Non-Operating Interest Income (Expense) $47.00M $43.00M $159.01M $44.05M $41.71M
Non-Operating Interest Income $48.00M $44.00M $163.09M $44.87M $42.70M
Non-Operating Interest Expense $1.00M $1.00M $4.08M $828,000.00 $993,000.00
Other Income (Expense) -$8.00M -$11.00M $64.98M -$309,000.00 -$5.62M
Gain on Sale of Security -$8.00M -$11.00M $77.37M $3.22M -$1.85M
Pretax Profit $532.00M $426.00M $1.28B $403.29M $386.05M
Tax $59.00M $60.00M -$13.43M -$129.66M $41.80M
Net Profit $472.00M $366.00M $1.29B $532.95M $344.26M
Profit from Continuing Operations $473.00M $366.00M $1.29B $532.95M $344.26M
Net Income to Parent Company $472.00M $366.00M $1.29B $532.95M $344.26M
Net Income to Common Stockholders $472.00M $366.00M $1.29B $532.95M $344.26M
Basic EPS $7.57 $5.90 $21.08 $8.67 $5.61
Diluted EPS $7.48 $5.52 $19.57 $8.06 $5.18
-Selling & Marketing Expense – – $429.19M – –
-General & Admin Expense – – $930.79M – –
Depreciation & Amortization & Depletion – – $7.08M – –
-Depreciation & Amortization – – $7.08M – –
Earnings from Equity Interest – – -$12.39M -$3.53M -$3.78M

Balance sheet

Line item 2026 Q2 2025 ANNUAL 2025 Q4 2025 Q2 2024 ANNUAL
Total Assets $10.03B $8.68B $8.68B $7.18B $6.20B
Total Current Assets $8.07B $6.90B $6.90B $5.83B $4.88B
Cash and Cash Equivalents & Short-Term Investments $5.18B $4.44B $4.44B $3.93B $3.38B
-Cash and Cash Equivalents $3.58B $3.49B $3.49B $2.09B $1.50B
-Short Term Investments $1.60B $948.75M $948.75M $1.84B $1.88B
Receivables $1.94B $1.66B $1.66B $1.20B $909.10M
-Accounts Receivable $1.83B $1.49B $1.49B $1.13B $817.71M
-Accrued Interest Receivable $24.00M $33.53M $33.53M $37.72M $40.21M
-Taxes Receivable $75.00M $123.12M $123.12M $32.73M $40.89M
-Other Receivables $10.00M $10.83M $10.83M $1.33M $10.29M
Prepaid Assets $572.00M $328.48M $328.48M $362.72M $187.95M
Inventory $371.00M $473.53M $473.53M $340.62M $407.23M
Total Non-Current Assets $1.96B $1.78B $1.78B $1.35B $1.32B
Net PPE $52.00M $48.25M $48.25M $45.80M $43.52M
Non Current Accounts Receivables $69.00M $86.21M $86.21M $100.47M $94.85M
Non-Current Prepaid Assets $24.00M $25.81M $25.81M $23.64M $23.64M
Goodwill and Other Intangible Assets $266.00M $272.10M $272.10M $218.98M $181.45M
Non-Current Deferred Assets $1.43B $1.30B $1.30B $899.61M $924.30M
Other Non-Current Assets $124.00M $4.84M $4.84M $46.68M $1.96M
Total Liabilities $1.62B $1.36B $1.36B $1.08B $704.24M
Total Current Liabilities $1.58B $1.32B $1.32B $1.04B $669.92M
Payables $925.00M $694.98M $694.98M $586.37M $372.09M
-Accounts Payable $718.00M $554.27M $554.27M $531.97M $342.23M
-Total Tax Payable $49.00M $42.21M $42.21M $18.16M $13.39M
-Other Payable $158.00M $98.50M $98.50M $36.24M $16.47M
Short-Term Debt and Capital Lease Obligation $11.00M $10.83M $10.83M $7.58M $6.53M
-Current Capital Lease Obligation $11.00M $10.83M $10.83M $7.58M $6.53M
Current Provisions $441.00M $402.03M $402.03M $320.23M $140.47M
Other Current Liabilities $1.00M – – – –
Total Non-Current Liabilities $40.00M $39.42M $39.42M $37.94M $34.32M
Long Term Debt and Capital Lease Obligation $36.00M $36.33M $36.33M $35.57M $32.52M
-Long Term Capital Lease Obligation $36.00M $36.33M $36.33M $35.57M $32.52M
Employee Benefits $4.00M $3.09M $3.09M $2.37M $1.80M
Other Non-Current Liabilities $1.00M – – – –
Total Equity $8.42B $7.32B $7.32B $6.10B $5.50B
Stockholders' Equity $8.42B $7.32B $7.32B $6.10B $5.50B
Capital Stock $7.00M $7.35M $7.35M $7.26M $7.23M
-Common Stock $7.00M $7.35M $7.35M $7.26M $7.23M
Additional Paid-In Capital $6.31B $6.19B $6.19B $6.03B $5.95B
Retained Earnings $558.00M -$279.77M -$279.77M -$1.16B -$1.57B
Gains/Losses Not Affecting Retained Earnings $1.54B $73.59M $73.59M $78.22M $66.71M
-Gross PPE – $83.97M $83.97M – $72.72M
-Accumulated Depreciation – -$35.72M -$35.72M – -$29.20M
Investments and Advances – $50.53M $50.53M $10.68M $49.70M
-Available for Sale Securities – $10.02M $10.02M – $14.88M
-Long Term Equity Investment – $3.38M $3.38M $10.68M $9.27M
-Other Intangible Assets – $272.10M $272.10M – $181.45M
Non-Current Deferred Liabilities – $0.00 $0.00 – $0.00
Other Equity Interests – $1.34B $1.34B $1.14B $1.05B
Other Current Assets – – – $1,000.00 –

Cash flow

Line item 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
Operating Cash Flow $685.19M -$82.75M -$420.33M -$862.81M -$606.81M
Net cash flow from continuing operations $685.19M -$82.75M -$420.33M -$862.81M -$606.81M
Net Income from Continuing Operations $1.05B -$21.65M -$425.05M -$720.34M -$348.75M
Gain/Loss from Continuing Operations $13.54M $8.08M $4.98M $1.14M $260,000.00
Depreciation & Depletion & Amortization $28.10M $17.53M $111.31M $104.34M $5.87M
Other Non-Cash Items $31.63M -$277,000.00 $2.07M – -$75.00M
Change in Working Capital -$422.63M -$325.17M -$308.89M -$375.72M -$340.95M
-Change in Receivables -$802.33M -$423.11M -$185.69M -$222.26M -$31.63M
-Change in Inventory -$98.95M -$96.00M -$83.03M -$119.28M -$83.88M
-Change in Prepaid Assets -$142.16M -$30.43M -$105.41M $0.00 $0.00
-Change in Payables and Accrued Expense $612.33M $246.34M $95.60M $329,000.00 $134.89M
-Change in Other Current Assets $8.48M -$21.97M -$30.36M -$34.51M -$44.97M
Net cash flow from investing $984.01M -$717.59M $308.21M -$461.18M -$347.07M
Net Cash Flow from Continuing Investing Activities $984.01M -$717.59M $308.21M -$461.18M -$347.07M
Net PPE Purchase and Sale -$6.17M -$1.80M -$812,000.00 -$837,000.00 -$3.62M
Net Intangibles Purchase and Sale -$105.52M -$66.50M -$43.00M -$102.99M -$117.81M
Net Business Purchase and Sale -$6.50M -$7.00M -$13.00M -$2.00M $0.00
Net Investment Purchase and Sale $939.52M -$753.94M $272.27M -$368.51M -$228.24M
Financing Cash Flow $233.01M $279.76M $1.34B $843.76M $1.12B
Net Cash Flow from Continuing Financing Activities $233.01M $279.76M $1.34B $843.76M $1.12B
Net Issuance Payments Of Debt -$4.11M -$7.64M -$3.80M -$4.17M -$3.86M
Net Common Stock Issuance $0.00 $0.00 $1.20B $760.95M $1.09B
Proceeds from Stock Option Exercised $278.38M $309.27M $158.26M $93.20M $33.43M
Net Other Financing Charges -$41.26M -$21.87M -$14.47M -$6.23M $438,000.00
Ending Cash Balance $3.49B $1.50B $2.05B $800.74M $1.33B
Net Change in Cash $1.90B -$520.58M $1.22B -$480.23M $167.46M
Beginning Cash Balance $1.50B $2.05B $800.74M $1.33B $1.22B
Effect of Exchange Rate Changes $89.15M -$28.33M $23.49M -$53.70M -$49.59M
Free Cash Flow $573.51M -$151.05M -$464.14M -$966.63M -$728.25M
Net Other Investing Changes – – – -$1,000.00 –
-Change In Other Working Capital – – – – -$315.37M
Scroll to Top